AU3006797A - Substituted 1, 3-benzodioxoles - Google Patents

Substituted 1, 3-benzodioxoles

Info

Publication number
AU3006797A
AU3006797A AU30067/97A AU3006797A AU3006797A AU 3006797 A AU3006797 A AU 3006797A AU 30067/97 A AU30067/97 A AU 30067/97A AU 3006797 A AU3006797 A AU 3006797A AU 3006797 A AU3006797 A AU 3006797A
Authority
AU
Australia
Prior art keywords
benzodioxoles
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU30067/97A
Other versions
AU730659B2 (en
Inventor
Gerardo De La Cruz Francisco
Adam Matthew Gilbert
George Theodore Grosu
Michael Sotirios Malamas
Fuk-Wah Sum
Aranapakam Mudumbai Venkatesan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU3006797A publication Critical patent/AU3006797A/en
Application granted granted Critical
Publication of AU730659B2 publication Critical patent/AU730659B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1896Compounds having one or more Si-O-acyl linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU30067/97A 1996-05-14 1997-05-09 Substituted 1, 3-benzodioxoles Ceased AU730659B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64597096A 1996-05-14 1996-05-14
US08/645970 1996-05-14
PCT/US1997/008148 WO1997043273A1 (en) 1996-05-14 1997-05-09 Substituted 1, 3-benzodioxoles

Publications (2)

Publication Number Publication Date
AU3006797A true AU3006797A (en) 1997-12-05
AU730659B2 AU730659B2 (en) 2001-03-08

Family

ID=24591209

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30067/97A Ceased AU730659B2 (en) 1996-05-14 1997-05-09 Substituted 1, 3-benzodioxoles

Country Status (10)

Country Link
EP (1) EP0901484A1 (en)
JP (1) JP2000510150A (en)
KR (1) KR20000011001A (en)
AU (1) AU730659B2 (en)
BR (1) BR9708948A (en)
CA (1) CA2254120A1 (en)
HU (1) HUP9902088A2 (en)
IL (1) IL126780A0 (en)
NZ (1) NZ332713A (en)
WO (1) WO1997043273A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3797108B1 (en) 2018-05-21 2022-07-20 Constellation Pharmaceuticals, Inc. Modulators of methyl modifying enzymes, compositions and uses thereof
CA3148444A1 (en) * 2019-07-24 2021-01-28 Constellation Pharmaceuticals, Inc. Ezh2 inhibition therapies for the treatment of cancers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061727A (en) * 1990-05-04 1991-10-29 American Cyanamid Company Substituted 5-(2-((2-aryl-2-hydroxyethyl)amino)propyl)-1,3-benzodioxoles
US5482971A (en) * 1993-10-01 1996-01-09 American Cyanamid Company Beta3 -adrenergic agents and their use in pharmaceutical compositions

Also Published As

Publication number Publication date
IL126780A0 (en) 1999-08-17
BR9708948A (en) 1999-08-03
CA2254120A1 (en) 1997-11-20
HUP9902088A2 (en) 2001-04-28
WO1997043273A1 (en) 1997-11-20
JP2000510150A (en) 2000-08-08
KR20000011001A (en) 2000-02-25
AU730659B2 (en) 2001-03-08
EP0901484A1 (en) 1999-03-17
NZ332713A (en) 2000-07-28

Similar Documents

Publication Publication Date Title
ZA977687B (en) Substituted 6,5-hetero-bicyclic derivatives
ZA977652B (en) Substituted 6,6-hetero-bicyclic derivatives
AU3356397A (en) Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
AU4073997A (en) 1,4-heterocyclic metallprotease inhibitors
AU1251697A (en) New substituted oxazolidinones
HK1018216A1 (en) New 19-nor-pregnene derivatives.
AU4578297A (en) New combination
AU2681895A (en) 8-aryl-1,6-naphthyridin-5-ones
ZA972056B (en) Substituted 1,2,3,4-tetrahydronaphthalene derivatives.
DE69723848D1 (en) 3-descladinose-2,3-anhydroerythromycin-derivate
AU1636297A (en) Novel 2,3-benzodiazepine derivatives
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
AU3620297A (en) Substituted triazoloazinesulphonamides
AU3771497A (en) Substituted p-trifluoromethylphenyluracils
ZA97928B (en) Novel heteroaryl-oxazolidinones.
AU1926397A (en) Substituted 1-methyl-3-benzyluracils
ZA974052B (en) New benzothiazolinones.
AU2964899A (en) 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
AU7449998A (en) 2,3-dihydrobenzofuran derivatives
AUPP003297A0 (en) 4,5-diaryloxazole compounds
AU1513597A (en) 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives
AU3006797A (en) Substituted 1, 3-benzodioxoles
AU2955597A (en) Substituted phenyluracils
AU5692398A (en) Substituted 5-amino-1,3,4-thiadiazole-2-thiones
AU2895097A (en) New thiazolopyridines

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired